President Donald Trump signs an executive orders during a press availability in the Oval Office of the White House on Sept. 5, 2025. Kevin Dietsch/Getty Images
Federal officials are resuming enforcement of regulations that dictate how pharmaceutical products can be advertised to consumers, the Trump administration said on Sept. 9, as President Donald Trump signed a new executive order.
The Food and Drug Administration (FDA) is restarting its enforcement of regulations that prohibit pharmaceutical ads from creating a “misleading impression” and require them to present a “fair balance of information,” a senior administration official told reporters on a call.
We had a problem loading this article. Please enable javascript or use a different browser. If the issue persists, please visit our help center.
Original News Source Link – Epoch Times
Running For Office? Conservative Campaign Consulting – Election Day Strategies!